B-SMART

Brain-Specific, Modular and Active RNA Therapeutics

Programm
Horizon 2020 & sub-programmes
Laufzeit
66 Monate (January 2017 – June 2022)
Projektförderung
≈ €6 million
Projektpartner
9
Technologie-Reifegrad
4-7

Worum es geht

B-SMART aims at designing and manufacturing modular nanoparticles via a quality-by-design protocol. These nanoparticles shall serve to deliver therapeutic RNAs to the brain and treat neurodegenerative diseases. B-SMART expects to arrive at a scale-able nanoparticle formulation with uniform characteristics that shows a strong pre-clinical evidence of therapeutic efficacy and is ready for clinical translation.

Koordination

Prof. Raymond Schiffelers

Universitair Medisch Centrum Utrecht

E-Mail senden

Explore THE COURT

Discover THE COURT, the EURICE environment where projects, expertise and partners connect across six innovation ecosystems.

THE COURT betreten